You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華森製藥(002907.SZ):收到6份藥品再註冊批准通知書
格隆匯 03-13 17:06

格隆匯3月13日丨華森製藥(002907.SZ)公佈,公司於近日收到重慶市藥品監督管理局核准簽發的6份《藥品再註冊批准通知書》。

1.安乃近片(0.25g、0.5g):用於高熱時的解熱,也可用於頭痛、偏頭痛、肌肉痛、關節痛、痛經等。本品亦有較強的抗風濕作用,用於急性風濕性關節炎,但因本品有可能引起嚴重的不良反應,很少在風濕性疾病中應用。

2.都梁軟膠囊:用於祛風散寒,活血通絡。用於頭痛屬風寒瘀血阻滯脈絡證者,症見頭脹痛或刺痛,痛有定處,反覆發作,遇風寒誘發或加重。

3.維生素C片:用於預防壞血病,也可用於各種急、慢性傳染疾病及紫癜等的輔助治療。

4.鹽酸特拉唑嗪膠囊:①用於改善良性前列腺增生症患者的排尿症狀,如:尿頻、尿急、尿線變細、排尿困難、夜尿增多、排尿不盡感等;②用於治療高血壓,可單獨應用或與其它抗高血壓藥同時使用。

5.注射用苦蔘素:用於慢性乙型肝炎的治療。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account